Ninety One (UK)
EW icon

Ninety One (UK)’s Edwards Lifesciences EW Stock Holding History

Ninety One (UK)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12B Sell
12,337,502
-58,641
-0.5% -$4.91M 2.5% 10
2026
Q1 		$993M Buy
12,396,143
+4,661,197
+60% +$384M 2.3% 9
2025
Q4 		$659M Sell
7,734,946
-173,626
-2% -$14.2M 1.41% 17
2025
Q3 		$615M Buy
7,908,572
+969,030
+14% +$75.7M 1.33% 20
2025
Q2 		$543M Sell
6,939,542
-64,875
-0.9% -$4.84M 1.27% 23
2025
Q1 		$508M Sell
7,004,417
-180,263
-3% -$12.9M 1.41% 23
2024
Q4 		$532M Sell
7,184,680
-127,048
-2% -$8.89M 1.42% 23
2024
Q3 		$483M Buy
7,311,728
+6,895,970
+1,659% +$501M 1.29% 24
2024
Q2 		$38.4M Sell
415,758
-183,565
-31% -$16.3M 0.11% 110
2024
Q1 		$57.3M Buy
599,323
+101,294
+20% +$8.51M 0.16% 96
2023
Q4 		$38M Buy
498,029
+480,496
+2,741% +$33.4M 0.11% 100
2023
Q3 		$1.21M Buy
17,533
+1,689
+11% +$136K ﹤0.01% 170
2023
Q2 		$1.49M Buy
+15,844
New +$1.38M ﹤0.01% 169

Other funds holding EW

WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Ninety One (UK)'s EW Position: Q2 2026 in Review

Ninety One (UK) reduced its Edwards Lifesciences (EW) stake by 0.47% in Q2 2026, selling an estimated $4.91M and leaving 12,337,502 shares worth $1.12B. The position accounts for 2.5% of the portfolio, ranked #10.

Ninety One (UK) first reported a position in EW in Q2 2023 and has held it in 13 quarters since. 327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ninety One (UK) held 12,337,502 shares of Edwards Lifesciences worth $1.12B as of Q2 2026.
  • Ninety One (UK) sold 58,641 Edwards Lifesciences shares in Q2 2026, an estimated $4.91M.
  • Edwards Lifesciences made up 2.5% of Ninety One (UK)'s portfolio in Q2 2026, its #10 holding.
  • Ninety One (UK) first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 13 quarters since.
  • 327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.